Previous Article | Next Article 
Journal of Clinical Microbiology, November 1998, p. 3359-3361, Vol. 36, No. 11
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Development and Evaluation of an Epstein-Barr Virus
(EBV) Immunoglobulin M Enzyme-Linked Immunosorbent Assay Based on the
18-Kilodalton Matrix Protein for Diagnosis of Primary EBV
Infection
K. H.
Chan,1
R. X.
Luo,2
H. L.
Chen,3
M. H.
Ng,2
W. H.
Seto,1 and
J. S. M.
Peiris2,*
Department of Microbiology, Queen Mary
Hospital,1 and
The University of Hong
Kong,2 Hong Kong, and
Department of
Pharmacology and Molecular Science, School of Medicine, John Hopkins
University, Baltimore, Maryland3
Received 14 May 1998/Returned for modification 7 July 1998/Accepted 19 August 1998
A new immunoglobulin M (IgM) enzyme-linked immunosorbent assay
(ELISA) based on the recombinant Epstein-Barr virus (EBV) matrix protein was developed. Compared to indirect immunofluorescence for the
detection of IgM antibody to the EBV capsid antigen on clinical
specimens, the sensitivity and specificity of the new IgM ELISA were 96 and 96%, respectively.
*
Corresponding author. Mailing address: Department of
Microbiology, University Pathology Building, Queen Mary Hospital
Compound, Pokfulam, Hong Kong. Phone: (852) 2855 4888. Fax: (852)
2855 1241. E-mail: microgen{at}hkucc.hku.hk.
Journal of Clinical Microbiology, November 1998, p. 3359-3361, Vol. 36, No. 11
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tedeschi, R., Luostarinen, T., Marus, A., Bzhalava, D., Ogmundsdottir, H. M., Dillner, J., De Paoli, P., Surcel, H.-M., Pukkala, E., Lehtinen, M., Lehtinen, T.
(2009). No Risk of Maternal EBV Infection for Childhood Leukemia. Cancer Epidemiol. Biomarkers Prev.
18: 2790-2792
[Abstract]
[Full Text]
-
Casey, J.L., Coley, A.M., Parisi, K., Foley, M.
(2009). Peptide mimics selected from immune sera using phage display technology can replace native antigens in the diagnosis of Epstein-Barr virus infection. Protein Eng Des Sel
22: 85-91
[Abstract]
[Full Text]
-
Fachiroh, J., Paramita, D. K., Hariwiyanto, B., Harijadi, A., Dahlia, H. L., Indrasari, S. R., Kusumo, H., Zeng, Y. S., Schouten, T., Mubarika, S., Middeldorp, J. M.
(2006). Single-Assay Combination of Epstein-Barr Virus (EBV) EBNA1- and Viral Capsid Antigen-p18-Derived Synthetic Peptides for Measuring Anti-EBV Immunoglobulin G (IgG) and IgA Antibody Levels in Sera from Nasopharyngeal Carcinoma Patients: Options for Field Screening. J. Clin. Microbiol.
44: 1459-1467
[Abstract]
[Full Text]
-
Casey, J. L., Coley, A. M., Street, G., Parisi, K., Devine, P. L., Foley, M.
(2006). Peptide mimotopes selected from a random Peptide library for diagnosis of epstein-barr virus infection.. J. Clin. Microbiol.
44: 764-771
[Abstract]
[Full Text]
-
Chan, K. H., Ng, M. H., Seto, W. H., Peiris, J. S. M.
(2001). Epstein-Barr Virus (EBV) DNA in Sera of Patients with Primary EBV Infection. J. Clin. Microbiol.
39: 4152-4154
[Abstract]
[Full Text]
-
Hinderer, W., Lang, D., Rothe, M., Vornhagen, R., Sonneborn, H. H., Wolf, H.
(1999). Serodiagnosis of Epstein-Barr Virus Infection by Using Recombinant Viral Capsid Antigen Fragments and Autologous Gene Fusion. J. Clin. Microbiol.
37: 3239-3244
[Abstract]
[Full Text]